Table 4.
Scale score correlations with patient reported clinical markers
| CD4 | Symptom score | Days spent in bed | Days of reduced activity | |
|---|---|---|---|---|
| MOS-HIV | ||||
| PHS | 0.18 | -0.58 | -0.68 | -0.41 |
| MHS | 0.25 | -0.63 | -0.41 | -0.18 |
| GHP | 0.19 | -0.43 | -0.13 | -0.18 |
| BP | 0.55 | -0.51 | -0.44 | -0.43 |
| PF | 0.30 | -0.48 | -0.74 | -0.46 |
| RF | 0.26 | -0.44 | -0.53 | -0.26 |
| SF | -0.04 | -0.39 | -0.40 | -0.09 |
| MH | 0.25 | -0.51 | -0.26 | -0.23 |
| EF | 0.32 | -0.41 | -0.48 | -0.29 |
| HD | 0.07 | -0.53 | -0.32 | -0.06 |
| CF | 0.14 | -0.49 | -0.36 | -0.05 |
| QL | 0.22 | -0.37 | -0.31 | -0.19 |
| HT | -0.03 | -0.14 | -0.12 | 0.16 |
| SF-12 | ||||
| PCS | 0.11 | -0.39 | -0.36 | -0.38 |
| MCS | -0.05 | -0.55 | -0.57 | -0.10 |